Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05159999 · ClinicalTrials.gov registry record · NA
The Home Blood Pressure (BP) Trial
A NA study of End Stage Renal Disease on Dialysis, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT05159999 is a NA study of End Stage Renal Disease on Dialysis that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 200 participants, above the 55-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (264% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT05159999, a NA study of End Stage Renal Disease on Dialysis, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The main study will be a two arm 10-month, cross-over randomized controlled trial of 200 participants treated with end-stage-kidney-disease treated with in-center hemodialysis in the Seattle and San Francisco area comparing a strategy of targeting home vs. pre-dialysis systolic blood pressure \<140 mmHg to reduce rates of intradialytic hypotension. The target systolic blood pressure of \<140 mmHg in both treatment groups will be achieved using an algorithm of dry weight adjustment and anti-hypertensive medication adjustment.
Conditions Studied
Interventions
- OTHER Dry weight target adjustment
- DRUG Anti-hypertensive medications
Study Locations (2)
California
- University of California San Francisco - San Francisco
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05159999
The ClinicalTrials.gov registry entry for NCT05159999 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 55-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (264% higher). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with End Stage Renal Disease on Dialysis appearing as the primary indexed condition, and to 2 interventions - of which Dry weight target adjustment is the first listed.
NCT05159999 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Washington.
Frequently Asked Questions
What is clinical trial NCT05159999 about?
NCT05159999 is a clinical study titled "The Home Blood Pressure (BP) Trial". The main study will be a two arm 10-month, cross-over randomized controlled trial of 200 participants treated with end-stage-kidney-disease treated with in-center hemodialysis in the Seattle and San Francisco area comparing a strategy of targeting home vs. pre-dialysis systolic blood pressure \<140 ...
What is the current status of trial NCT05159999?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-02-02. Estimated completion is 2026-04-30.
What conditions does trial NCT05159999 study?
This clinical trial studies the following conditions: End Stage Renal Disease on Dialysis.
What interventions are being tested in trial NCT05159999?
The interventions under investigation include: Dry weight target adjustment (OTHER), Anti-hypertensive medications (DRUG).
Who is sponsoring clinical trial NCT05159999?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05159999 being conducted?
This trial has 2 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease on Dialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
RECRUITING · NA
-
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
RECRUITING · NA
-
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
ACTIVE NOT RECRUITING · NA
-
Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
COMPLETED · NA
-
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
COMPLETED · NA
-
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.